Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining certain treatments, including FOL005, may improve healing of difficult wounds.

Topical glucocorticoids thin the skin and change collagen structure.

EGFR inhibitors for lung cancer can cause severe skin issues.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Microneedling may help treat some autoimmune skin conditions, but more research is needed.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Regulating keratinocyte growth in engineered skin can improve wound healing.

Trichodysplasia spinulosa can occur after a heart transplant due to immunosuppressive drugs.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Different doses of triamcinolone injections work equally well for skin conditions.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Erythema multiforme-like lesions can occur in lupus without drug use or herpes infection.

New technologies replicate human skin for testing without animals.

A handheld dermoscope helps assess treatment success in alopecia areata.

Dermocosmetics significantly reduce itch and skin sensitivity in atopic dermatitis patients.

Amivantamab treatment often causes skin issues that can affect quality of life and treatment continuation.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.